Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NCATS

Novel ALK2 Inhibitors And Methods For Inhibiting BMP Signaling

  • Read more about Novel ALK2 Inhibitors And Methods For Inhibiting BMP Signaling
Germany
18790880.1
Filed on 2018-04-26

Novel ALK2 Inhibitors And Methods For Inhibiting BMP Signaling

  • Read more about Novel ALK2 Inhibitors And Methods For Inhibiting BMP Signaling
France
18790880.1
Filed on 2018-04-26

REMODILINS FOR AIRWAY REMODELING AND ORGAN FIBROSIS

  • Read more about REMODILINS FOR AIRWAY REMODELING AND ORGAN FIBROSIS
European Patent
20783111.6
Filed on 2020-04-02

REMODILINS FOR AIRWAY REMODELING AND ORGAN FIBROSIS

  • Read more about REMODILINS FOR AIRWAY REMODELING AND ORGAN FIBROSIS
US Application 17/594,086
Filed on 2021-10-01

REMODILINS FOR AIRWAY REMODELING AND ORGAN FIBROSIS

  • Read more about REMODILINS FOR AIRWAY REMODELING AND ORGAN FIBROSIS
Patent Cooperation Treaty
PCT/US2020/026371
Filed on 2020-04-02

REMODILINS TO PREVENT OR TREAT CANCER METASTASIS, GLAUCOMA, AND HYPOXIA

  • Read more about REMODILINS TO PREVENT OR TREAT CANCER METASTASIS, GLAUCOMA, AND HYPOXIA
US Application 17/594,090
Filed on 2021-10-01

Remodelins, A New Class Of Compounds To Prevent Or Treat Cancer Metastasis Or Glaucoma

  • Read more about Remodelins, A New Class Of Compounds To Prevent Or Treat Cancer Metastasis Or Glaucoma
Patent Cooperation Treaty
PCT/US2020/026383
Filed on 2020-04-02

POTENT AND SELECTIVE DOPAMINE D3 ANTAGONISTS

  • Read more about POTENT AND SELECTIVE DOPAMINE D3 ANTAGONISTS
Patent Cooperation Treaty
PCT/US2024/036149
Filed on 2024-06-28

Combinations of Retinaldehyde Dehydrogenase 1 (RALDH1) Inhibitors and Immunostimulators and Methods Using Same

  • Read more about Combinations of Retinaldehyde Dehydrogenase 1 (RALDH1) Inhibitors and Immunostimulators and Methods Using Same
Patent Cooperation Treaty
PCT/US2024/020160
Filed on 2024-03-15

NOVEL ALK2 INHIBITORS AND METHODS FOR INHIBITING BMP SIGNALING

  • Read more about NOVEL ALK2 INHIBITORS AND METHODS FOR INHIBITING BMP SIGNALING
European Patent
24155493.0
Filed on 2024-02-02

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 37
  • Page 38
  • Page 39
  • Page 40
  • Page 41
  • Page 42
  • Page 43
  • Page 44
  • Page 45
  • …
  • Next page ››
  • Last page Last »
Subscribe to NCATS
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health